New York · 2025 Regular Session · Bill
S 4664: Directs the commissioner of health to conduct a study on the use of ibogaine as a treatment for post-traumatic stress disorder
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
S 4664 is a bill introduced in the New York Senate on February 11, 2025. According to its official title, it concerns: Directs the commissioner of health to conduct a study on the use of ibogaine as a treatment for post-traumatic stress disorder. Primary sponsor: Jake Ashby (Republican/Conservative). It lists 1 additional sponsor. Most recent recorded action (January 7, 2026): REFERRED TO HEALTH.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Directs the commissioner of health, in conjunction with the commissioners of mental health and veterans' services, to conduct a study on the use of ibogaine as a treatment for post-traumatic stress disorder, and the increasing rate of PTSD diagnoses in veterans and first responders.
Sponsors
Sponsors by party (alphabetical): Democratic 1 · Republican/Conservative 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Jake Ashby | Primary sponsor | Republican/Conservative | Senate | 43 |
| Nathalia Fernández | Co-sponsor | Democratic | Senate | 34 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- REFERRED TO HEALTH
- REFERRED TO HEALTH